| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996726 | Practical Radiation Oncology | 2015 | 6 Pages |
Abstract
Nearly 25% of men with GS 6 CaP diagnosed by standard transrectal ultrasound biopsy may experience GS upgrading when a subsequent MRI-ultrasound fusion biopsy is performed. The most important single predictor of upgrading is a category 5 ROI on multiparametric MRI. GS upgrading may influence treatment decisions. Therefore, MRI-guided biopsy should be considered prior to formulating a management strategy in patients whose conventional biopsy reveals low-risk CaP.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mitchell MD, Amar U. MD, Daniel J. MD, Jiaoti MD, Fred PhD, Patricia BS, Patrick A. MD, Leonard S. MD,